Cardiff Oncology, Inc. Common Stock (CRDF) News

Latest headlines that mention CRDF, newest first · each headline opens the original publisher

CRDF quote

Last price: $0.80
Day change: -11.35%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

CRDF headlines

latest coverage

Not much coverage yet. CRDF has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha News 1mo ago

Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit - Slideshow

General T2CRDF

Investing.com 2mo ago

William Blair downgrades Cardiff Oncology stock rating on rights uncertainty

General T3CRDF

Yahoo Finance 3mo ago

Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital

General T2CRDF

Seeking Alpha 3mo ago

Cardiff Oncology announces $10M direct offering

General T2CRDF

Yahoo Finance 3mo ago

Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential?

General T2CRDF

Seeking Alpha News 4mo ago

Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer - Slideshow

General T2CRDF

Seeking Alpha News 4mo ago

Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer Transcript

General T2CRDF

Investing.com 4mo ago

H.C. Wainwright cuts Cardiff Oncology stock rating on license termination

General T3CRDF

Seeking Alpha 5mo ago

Cardiff Oncology GAAP EPS of -$0.18 misses by $0.05, revenue of $0.04M misses by $0.04M

Earnings T2CRDF

CRDF news alerts

Get an alert by email or push when a new headline mentions CRDF.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.